Literature DB >> 14043543

THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. I. BACKGROUND.

N NATHANSON, A D LANGMUIR.   

Abstract

Entities:  

Keywords:  EPIDEMIOLOGY; HISTORY; POLIOMYELITIS; POLIOVIRUS VACCINE; UNITED STATES

Mesh：

Substances：

Year:  1963        PMID： 14043543     DOI： 10.1093/oxfordjournals.aje.a120327

Source DB:  PubMed          Journal:  Am J Hyg        ISSN： 0096-5294


× No keyword cloud information.
  22 in total

1.  SURVEILLANCE OF SALK VACCINATION IN ENGLAND AND WALES 1956-61.

Authors:  A T RODEN
Journal:  Proc R Soc Med       Date:  1964-06

2.  POLIOVIRUS VACCINES AND THE CONTROL OF POLIOMYELITIS.

Authors:  C H STUART-HARRIS
Journal:  Proc R Soc Med       Date:  1964-06

3.  SURVEILLANCE OF THE SAFETY OF ORAL POLIOMYELITIS VACCINE IN ENGLAND AND WALES 1962-4.

Authors:  D L MILLER; N S GALBRAITH
Journal:  Br Med J       Date:  1965-08-28

Review 4.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

Review 5.  Parallel mechanisms in neuropathogenesis of enteric virus infections.

Authors:  L A Morrison; B N Fields
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 6.  Acute Flaccid Paralysis and Enteroviral Infections.

Authors:  Ari Bitnun; E Ann Yeh
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

7.  What should an ideal vaccine postlicensure safety system be?

Authors:  Marie R Griffin; M Miles Braun; Kenneth J Bart
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

8.  Fifty Years of Global Immunization at CDC, 1966-2015.

Authors:  Eric E Mast; Stephen L Cochi; Olen M Kew; K Lisa Cairns; Peter B Bloland; Rebecca Martin
Journal:  Public Health Rep       Date:  2016-12-19       Impact factor: 2.792

9.  Polio, still lurking in the shadows.

Authors:  Anthony N van den Pol
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

10.  A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.

Authors:  Kristina Abel; Lisa Strelow; Yujuan Yue; Meghan K Eberhardt; Kimberli A Schmidt; Peter A Barry
Journal:  Vaccine       Date:  2008-08-27       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.